Blue Water Vaccines Inc. (BWV)
NASDAQ: BWV
· Real-Time Price · USD
0.18
-0.01 (-7.07%)
At close: Dec 21, 2023, 8:59 PM
-7.07% (1D)
| Bid | n/a |
| Market Cap | 3.41M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -18.22M |
| EPS (ttm) | -1.08 |
| PE Ratio (ttm) | -0.16685185185185186 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 520,290 |
| Avg. Volume (20D) | 435,531 |
| Open | 0.20 |
| Previous Close | 0.19 |
| Day's Range | 0.18 - 0.20 |
| 52-Week Range | 0.16 - 1.95 |
| Beta | 0.00 |
About BWV
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BW...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 18, 2022
Employees 12
Stock Exchange NASDAQ
Ticker Symbol BWV